Pancreatic cancer is the fourth leading cause of cancer death in the developed world 1 . Both inherited high-penetrance mutations in BRCA2 (ref. 2), ATM 3 , PALB2 (ref. 4), BRCA1 (ref. 5), STK11 (ref. 6), CDKN2A 7 and mismatch-repair genes 8 and low-penetrance loci are associated with increased risk 9-12 .
We conducted a two-stage genome-wide association study (GWAS) of pancreatic cancer ( Fig. 1) . First, genome-wide genotyping of 8,052 subjects from 9 studies within the Pancreatic Cancer Case-Control Consortium (PanC4) ( Supplementary Table 1 ) was conducted using the HumanOmniExpressExome-8v1 array. The overall study was approved by the Johns Hopkins Institutional Review Board (IRB). Each individual study obtained IRB approval from their parent institution. After quality control ( Fig. 1 , Online Methods and Supplementary Table 2), 7,956 individuals (4,164 cases and 3,792 controls) and 654,470 SNPs with call rates greater than 98% were analyzed. Unconditional logistic regression analysis adjusted for age and the first seven principalcomponent eigenvectors was conducted under the log-additive genetic model ( Fig. 2 and Supplementary Fig. 1) .
Analysis of 7,956 newly genotyped PanC4 individuals identified a new locus at 17q25.1 (LINC00673, rs7214041, OR = 1.38, 95% CI = 1.26-1.51, P = 1.95 × 10 −10 ) significantly associated with pancreatic cancer risk ( Table 1 , "PanC4" column). In addition, we replicated regions that had previously been reported to be associated with pancreatic cancer in the European-ancestry population ( Supplementary  Table 3 ). These included 9q34.2 (ref. 9 ; ABO, rs505922, OR = 1.27, 95% CI = 1.19-1. 35 , P = 1.72 × 10 −13 ), 13q22.1 (ref. 10 ; KLF5, rs9543325, OR = 1.24, 95% CI = 1.16-1.32, P = 2.26 × 10 −10 ), 5p15.33 (ref. 10 ; CLPTM1, rs401681, OR = 1.2, 95% CI = 1.13-1.28, P = 2.7 × 10 −8 ), 13q12.2 (ref. 11 ; PDX1, rs9581943, OR = 1.17, 95% CI = 1.10-1.24, P = 1.94 × 10 −7 ), 1q32.1 (ref. 10 ; NR5A2, rs3790844, OR = 0.83, 95% CI = 0.77-0.90, P = 3.05 × 10 −6 ), 7q32. 3 (ref. 11 ; LINC-PINT, rs6971499, OR = 0.81, 95% CI = 0.74-0.88, P = 7.1 × 10 −6 ), 5p15. 33 (ref. 11 ; TERT, rs2736098, OR = 0.85, 95% CI = 0.78-0.93, P = 2.31 × 10 −5 ), 16q23.1 (ref. 11 ; BCAR1, rs7190458, OR = 1.4, 95% CI = 1.22-1.60, P = 1.01 × 10 −4 ) and 22q12. 1 (ref. 11 ; ZNRF3, rs16986825, OR = 1.14, 95% CI = 1.04-1.24, P = 2.72 × 10 −3 ). In contrast, other than 2p13.3 (ETAA1, rs2035565, OR = 1.15, 95% CI = 1.07-1.25, P = 2.69 × 10 −4 ) ( Supplementary Table 3 ), we observed no evidence of association (P > 0.05) for SNPs previously reported to be associated (P < 1 × 10 −6 ) with pancreatic cancer in Asian populations 12, 13 . Although all ancestry groups were included in our analyses, over 92% of our study population reported European ancestry. We obtained similar results when analysis was limited to individuals reporting European ancestry. Because of limited sample sizes, we did not conduct independent analysis of other ancestry groups (data not shown).
We then conducted a genome-wide meta-analysis of the PanC4 data with data from PanScan 1 (ref. 9 ) and PanScan 2 (ref. 10) (combined stage 1; Fig. 1 (Fig. 3) . A quantilequantile plot ( Supplementary Fig. 2 ) indicated appropriate control of type I errors, with genomic inflation λ values of 1.025 for PanC4, 0.998 for PanScan 1 and 1.017 for PanScan 2.
The combined stage 1 analysis ( Table 1 , "Combined stage 1" column) yielded a second new region of association at 3q29 (TP63, rs9854771, OR = 0.87, 95% CI = 0.83-0.92, P = 4.08 × 10 −8 ). A second 9 1 2 VOLUME 47 | NUMBER 8 | AUGUST 2015 Nature GeNetics l E T T E R S SNP at 17q25.1 (rs11655237, OR = 1.27, 95% CI = 1.19-1.36, P = 6.74 × 10 −12 ), which is in high linkage disequilibrium (LD; r 2 = 0.95) with rs7214041, also gave significant evidence of association in these combined data.
We next conducted a stage 2 analysis in an independent set of 2,497 cases and 4,611 controls from the PANcreatic Disease ReseArch (PANDoRA) 18 consortium. We selected 25 SNPs from 23 independent regions ( Supplementary Table 5 ) with association P values below 1 × 10 −5 in either the PanC4 or combined stage 1 analysis. When multiple SNPs in a single region were associated, the most significant SNP was selected; SNPs at 17q25.1 and 2p13.3 were exceptions. After quality control (Online Methods and Supplementary Table 6 ), 2,287 cases and 4,205 controls from the PANDoRA study were analyzed. Age-adjusted association analyses by country were carried out, and results were combined using a fixed-effects model. We observed independent evidence of association at 17q25.1 in the PANDoRA study (rs7214041, OR = 1.25, 95% CI = 1.11-1.41, P = 3.37 × 10 −4 ; Table 1 , "PANDoRA" column).
Combined analysis of the stage 1 and 2 data for the 25 SNPs ( Table 1 , "combined stage 1 and 2" column, and Supplementary Table 5 ) identified two additional significantly associated loci: 2p13.3 (ETAA1, rs1486134, OR = 1.14, 95% CI = 1.09-1.19, P = 3.36 × 10 −9 ) and 7p13 (SUGCT, rs17688601, OR = 0.88, 95% CI = 0.84-0.92, P = 1.41 × 10 −8 ). Promising signals ( Supplementary Table 7 ) arose at 18q21.2 (GRP, rs1517037, OR = 0.87, 95% CI = 0.83-0.92, P = 3.17 × 10 −7 ), 12q24.31 (HNF1A, rs7310409, OR = 1.11, 95% CI = 1.06-1.15, P = 6.34 × 10 −7 ), 1p13.1 (WNT2B, rs351365, OR = 0.89, 95% CI = 0.85-0.93, P = 7.39 × 10 −7 ) and 20q13.11 (rs6073450, OR = 1.11, 95% CI = 1.06-1.15, P = 9.21 × 10 −7 ).
We identified and replicated a new region for association at 17q25.1 (Fig. 4a) . Two highly correlated variants (rs11655237 and rs7214041; r 2 = 0.95) were associated with pancreatic cancer risk. Variant rs7214041 is intronic to LINC00673 (long intergenic nonprotein-coding RNA 673). rs11655237, a noncoding transcript variant, shows substantial DNase hypersensitivity in multiple cancer cell lines and binds transcription factors including P300, FOXA1, FOXA2 and the DNA repair protein RAD21, according to HaploReg v2 (ref. 19 ). HaploReg v2 also indicated that rs7214041 alters regulatory motifs for HNF1 (ref. 19) . Interestingly, we also found suggestive evidence of an association with rs7310409 located in the HNF1A locus (12q24.31; Supplementary Fig. 3a and Supplementary Table 7 ). A recent study of the pancreatic cancer transcriptome suggests that HNF1A may act as a tumor suppressor in pancreatic cancers 20 . Variation in HNF1A has been associated with risk of type 2 diabetes 21, 22 , which is a well-established risk factor for pancreatic cancer [23] [24] [25] . HNF1A variation is also associated with maturity-onset diabetes of the young (MODY) 26 . Furthermore, variants in HNF1A (in particular, rs7310409) and HNF4A were identified as risk factors for pancreatic cancer in pathway-based and candidate SNP-based analyses of the PanScan data 27, 28 .
We also identified significant association for two variants in high LD (rs9854771 and rs1515496; r 2 = 0.99) located in an intron of TP63 at 3q29 ( Fig. 4b) . p63 is a p53 homolog implicated in tumorigenesis and metastasis 29 by having a role in cell cycle arrest and apoptosis. Overexpression of p63 can mimic p53 activation in certain experimental models 30 . Interestingly, different isoforms of p63 have opposing effects; TAp63 has tumor-suppressive effects, whereas DNp63 has oncogenic effects 31 . Danilov and colleagues have suggested that DNp63α is the predominant isoform in pancreatic cancer cell lines and promotes the growth, motility and invasion of pancreatic cancer cells 32 . Previous GWAS of lung cancer and bladder cancer have demonstrated significant evidence of association for SNPs in TP63 (refs. [33] [34] [35] [36] [37] . In HaploReg query of this region, both variants were predicted to be conserved elements according to GERP score, suggesting that they have functional roles.
Our analysis identified genome-wide significance in a region at 2p13.3 (rs1486134). A pancreatic cancer GWAS in Han Chinese subjects 12 found suggestive evidence for another SNP at 2p13.3 (rs2035565) ( Supplementary Table 3 ). High LD is present throughout this region ( Fig. 4c) , including strong LD between rs1486134 and rs2035565 in European and Asian populations, based on 1000 Genomes Project 15 samples (r 2 = 0.91 and 0.90, respectively). This region includes the gene ETAA1 (Ewing tumor-associated antigen 1), npg l E T T E R S also known as ETAA16, which may function as a tumor-specific cell surface antigen in the Ewing family of tumors 38 . We observed significant association at 7p13 for rs17688601, located in an intron of the SUGCT gene (encoding succinyl-CoA:glutarate-CoA transferase; also known as C7orf10) (Fig. 4d) . This variant is predicted in HaploReg to alter binding of HNF1-HNF4 and other DNA-binding proteins 19 . The SUGCT protein is involved in glutarate metabolism, and mutations in SUGCT are associated with glutaric aciduria 39 . Although there is evidence of altered tricarboxylic acid cycle metabolism in pancreatic cancer 40 , the role of SUGCT in pancreatic cancer risk is unclear.
Combined stage 1 and 2 analysis identified suggestive evidence of association (P < 1 × 10 −6 ) in four regions: 12q24.31 (HNF1A) ( Supplementary  Fig. 3a) , 18q21.2 (GRP) ( Supplementary Fig. 3b ), 1p13.1 (5′ end of WNT2B) (Supplementary Fig. 3c ) and 20q13.11 ( Supplementary  Fig. 3d ). GRP (gastrin-releasing peptide) expression has been associated with pancreatic tumor growth in vitro 41 . WNT signaling has an important role in pancreas development. WNT2B (wingless-type MMTV integration site family, member 2B) is overexpressed in pancreatic cancer and has been associated with decreased survival 42 . The 20q13.11 variant is located ~20 kb away from the HNF4A (MODY) gene, mutations of which are associated with early-onset diabetes 43 .
In the PanC4 study, we observed 11 SNPs on chromosome 9q31.3 ( Supplementary Fig. 3e ) in moderate to high LD (r 2 values between 0.6 and 1) with association P values from 7.00 × 10 −8 to 2.73 × 10 −6 , including rs10991043 (OR = 1.19, 95% CI = 1.12-1.26, P = 7.00 × 10 −8 ) near the SMC2 gene (encoding structural maintenance of chromosome 2). This gene has an important role in DNA repair in humans. Although there was no evidence of association in the other study populations examined, the strong signal across multiple SNPs in PanC4 suggests that this region merits further investigation.
Further functional characterization of these associated regions is needed, including examination of whether these SNPs are functional through expression quantitative trait locus (eQTL) activity. Performing eQTL analysis of pancreatic tissues is challenging. Normal pancreatic tissue primarily comprises acinar cells (>90%) whereas pancreatic ductal adenocarcinoma has a ductal phenotype, and the appropriate normal tissue to analyze is unclear because the cell of origin for pancreatic ductal adenocarcinomas is debated. eQTL analysis of pancreatic tumor tissue is also problematic because tissue from pancreatic ductal adenocarcinomas contains a variable mixture of cell types, including fibroblasts, multiple types of immune cells, nonneoplastic pancreatic cells and cancer cells, with cancer cells representing only a minority of the total cell population. Furthermore, gene expression analysis of normal pancreatic tissue is often limited by the RNA degradation associated with high-level RNase expression in pancreatic acinar cells. An ideal study of pancreatic eQTLs for pancreatic cells would take into account these challenges.
Smoking is a well-established risk factor for pancreatic cancer [44] [45] [46] [47] . For all nine SNPs listed in Table 1 and Supplementary Table 7 , we conducted an analysis stratified by smoking status (ever smoker versus never smoker) in PanC4 samples. No qualitative differences in effect size between current smokers and never smokers were observed (data not shown). Furthermore, when we included an interaction term in the model, this term was not significant at a threshold of P < 0.05.
We estimated the heritability of pancreatic cancer due to common GWAS SNPs using data from PanC4 samples of European ancestry with only directly genotyped SNPs (620,357 SNPs for 3,828 cases and 3,551 controls) as well as the combined data set (268,681 SNPs for 7,032 cases and 6,866 controls). Using a disease prevalence of 0.0149, reflecting the lifetime risk of pancreatic cancer, we estimated that 16.4% (95% CI = 10.4-22.4%) in PanC4 and 13.1% (95% CI = 9.9-16.3%) npg l E T T E R S in the combined data set of the total phenotypic variation was explained by common SNPs across the genome. The established associated regions (loci in Table 1 and Supplementary Table 3 ) accounted for 3.0% (95% CI = 2.0-3.9%) and 2.1% (95% CI = 1.7-3.1%) of the total phenotypic variation in the Panc4 population and the combined data set, respectively.
We have identified several new regions involved in pancreatic cancer susceptibility and provide additional evidence to support many of the established associations. Although it is of interest that many of these highly associated variants are located in the introns of genes, these associations could be due to more distant genomic effects. Follow-up studies, including functional analyses, are needed to fully Chr 
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Methods and any associated references are available in the online version of the paper. 56 and Yale University 57 ( Supplementary  Table 1 ). Cases were defined as individuals with adenocarcinoma of the pancreas. DNA samples for these individuals from PanC4, 180 study duplicates, 176 HapMap control samples and 26 replicates from the previous pancreatic cancer GWAS PanScan 2 (ref. 10) were genotyped on the IlluminaHumanOm niExpressExome-8v1 array at the Johns Hopkins Center for Inherited Disease Research (CIDR). Genotypes were called using GenomeStudio version 2011.1, Genotyping Module 1.9.4 and GenTrain version 1.0.
Genotyping results were inspected for quality by assessing the missing call rate, allelic imbalance, heterozygosity, discordance in reported versus genotyped sex, relatedness, ancestry and chromosomal anomalies. Unexpected relatedness between pairs of samples was assessed using the method of moments 58 , implemented in SNPRelate 59 . The median genotype call rate was 99.9%, with all individuals having a call rate greater than 98%. After removing individuals with excessive allele sharing, duplicates and subjects with incomplete information on age, 7,956 subjects (4,164 cases and 3,792 controls) were available for statistical analyses (Supplementary Table 2 ). SNPs with the following characteristics were excluded from statistical analyses: positional duplicates, more than two discordant calls in study duplicates, technical failures or a missing call rate greater than 2%, more than one mendelian error in HapMap control trios, Hardy-Weinberg equilibrium P value < 1 × 10 −6 , sex difference in allele frequency greater than 0.2 for autosomes/XY in samples of European ancestry and MAF less than 0.005. Overall, 654,470 SNPs passed the quality control filters applied; the median missing call rate was 0.024%, and 98% of SNPs had a missing call rate less than 1% (Supplementary Table 2) .
PanScan 1 and PanScan 2 quality control. PanScan 1 and PanScan 2 data were obtained from the database of Genotypes and Phenotypes (dbGaP) 60 Table 4 ).
Association analysis. To investigate population structure, principalcomponents analysis (PCA) was conducted separately for PanC4, PanScan 1 and PanScan 2 using SNPRelate 59 (Supplementary Fig. 4 ). Genotype imputation was performed separately for PanScan 1, PanScan 2 and PanC4 using IMPUTE v2 (ref. 14) . Because PanScan 1 and PanScan 2 SNPs were originally mapped using an older genome assembly (NCBI Build 36), we converted their genome positions to genome assembly NCBI Build 37 coordinates using liftOver. Markers not identified in the Build 37 assembly were removed. To decrease computational time, we prephased genotypes to produce bestguess haplotypes using SHAPEIT v2 software 62 After imputation, SNPs with quality scores <0.3 were excluded from all subsequent analysis. Only SNPs directly genotyped in PanC4, PanScan 1 or PanScan 2 and passing quality control filters were retained for analysis. This filtering resulted in 866,891 SNPs in the combined stage 1 analysis. The expected genotype counts were then analyzed using the frequentist test option of SNPTEST 63 . Decade of age and eigenvectors from PCA were included as covariates. The number of eigenvectors to include was chosen on the basis of inspection of the scree plot and P values for association between eigenvectors and pancreatic cancer status. The results from each study were then combined using a fixed-effects inverse-standard error approach implemented in METAL 17 (Supplementary Table 5 , "Combined stage 1" column). Test statistic inflation (λ) was estimated to be 1.025 for PanC4, 0.998 for PanScan 1 and 1.017 for PanScan 2. Test statistics for PanC4 and PanScan 2 were adjusted to account for small amounts of population stratification using METAL's genomic control option. Our sample size gave us over 80% power to detect an OR of 1.2 for SNPs with a MAF greater than 0.20. Manhattan and quantilequantile plots of PanC4 GWAS are shown in Figure 2 and Supplementary  Figure 1 , respectively. Manhattan and quantile-quantile plots showing association results from the combined stage 1 analysis are shown in Figure 3 and Supplementary Figure 2 , respectively. To examine whether our association results were confounded by population stratification, we conducted a secondary analysis restricting our samples to those of European ancestry, on the basis of PCA performed with PanC4 and HapMap 3 samples. The loci identified through association testing did not change, and their ORs and P values did not vary substantially (data not shown).
Stage 2 methods.
PANDoRA replication study. Twenty-five SNPs from 23 independent regions identified as showing evidence of association (P < 1 × 10 −5 ) in either the PanC4 analysis or the combined stage 1 analysis were genotyped in samples from the PANDoRA 18 consortium with TaqMan technology. These samples were drawn from case-control studies in six European countries: the Czech Republic, Germany, Greece, Italy, Lithuania and Poland. In total, 2,497 cases with pancreatic cancer and 4,611 controls were genotyped. Eight percent of samples were duplicates, and overall concordance was >99%. The features of the PANDoRA data set are shown in Supplementary Table 6 . Samples missing data for more than two SNPs (~15%) or missing covariate information were excluded from analyses. In total, 2,287 cases and 4,205 controls from the PANDoRA study remained after quality control.
Because PANDoRA is a collection of samples from various centers, we analyzed each country separately. Logistic regression models with additive effects of each allele were fit, as implemented in PLINK 58 ( Supplementary Table 5 , "PANDoRA" column). Two SNPs, rs16867971 for Greece and rs10850078 for Lithuania, showed evidence of departure from Hardy-Weinberg equilibrium in controls (P < 0.001). The SNP violating Hardy-Weinberg equilibrium was not analyzed for that country. A final fixed-effects meta-analysis of PanC4, PanScan 1, PanScan 2 and PANDoRA data (combined stage 1 and 2 analysis) was then conducted using METAL 17 on the 25 SNPs chosen for inclusion in stage 2. Results are shown in Supplementary Table 5 ("Combined stage 1 and 2" column). To further interrogate these regions, we examined all 1000 Genomes Project-imputed SNPs (as described above) in regions with significant or suggestive (P < 1 × 10 −6 ) evidence of association ( Fig. 4 and  Supplementary Fig. 3) .
In our combined stage 1 analysis (Supplementary Table 5 , "Combined stage 1" column), two SNPs selected for replication were observed to have heterogeneity P values below 0.001. When restricting our analysis to individuals of European ancestry, heterogeneity P values from the meta-analysis remained virtually unchanged, implying that the heterogeneity was not due to population stratification. One SNP, rs16867971, was directly genotyped in PanC4 and imputed in PanScan 1 and PanScan 2. We found evidence of association for rs16867971 in PanC4 but not in PanScan 1 or PanScan 2 (P > 0.05). The second SNP, rs6706539, was also directly genotyped in PanC4 and imputed in PanScan 1 and PanScan 2. For rs6706539, the A allele was associated with increased risk in PanScan 1 and PanScan 2 (P = 0.008 and 0.04, respectively) but was protective in PanC4 (P = 3.4 × 10 −6 ). Upon examination of the imputed and non-imputed SNPs adjacent to rs6706539, we found that r 2 values between this SNP and other SNPs within 10 kb were low, ranging from 0.05 to 0.18 in 1000 Genomes Project CEU (European ancestry) samples. It is possible that the low LD made imputation of this SNP rather difficult. Additionally, inspection of the alleles coded as reference and alternate alleles for this SNP in PanC4 and the 1000 Genomes Project suggests that this oddity is not due to differences in strand alignment.
Forest plots of our top hits (Supplementary Fig. 5a-i) showing the magnitude of ORs for each study population demonstrate that, for the majority of the top SNPs, those with a P value <1 × 10 −6 , the direction of effect was consistent across populations. Additionally, none of the top SNPs showed significant heterogeneity (at a threshold of P < 0.05) in the combined stage 1 and 2 analysis. However, in many instances, the effect size in the PanScan 1
